BioCentury | Oct 4, 2019
Finance

Biotechs likely to flood IPO market ahead of 2020 election

...Co. Ltd. (Shanghai) 7/3/19 $100.2 Mkt (drug) Annovis Bio Inc. (NYSE-M) 7/2/19 $10 Ph II CNS Pharmaceuticals Inc....
BioCentury | Jul 13, 2019
Finance

How crossover, insider support and big money correlated with performance across 1H19 IPOs

...7/3/19 Up to $100.2 Mkt (drug) Livongo Health Inc. 6/28/19 Up to $100 Mkt (tools) CNS Pharmaceuticals Inc....
BioCentury | Jun 28, 2019
Financial News

June 28 Financial Quick Takes: Karuna rises after IPO; plus Chi-Med, BeiGene and more

...and market capitalization thresholds for a general listing. Brain cancer company files for NASDAQ IPO CNS Pharmaceuticals Inc....
...2020 (see "Aslan's Change of Course" ). Paul Bonanos, Associate Editor BeiGene Ltd. Hutchison China MediTech Ltd. Karuna Therapeutics Inc. berubicin CNS Pharmaceuticals Inc....
Items per page:
1 - 3 of 3
BioCentury | Oct 4, 2019
Finance

Biotechs likely to flood IPO market ahead of 2020 election

...Co. Ltd. (Shanghai) 7/3/19 $100.2 Mkt (drug) Annovis Bio Inc. (NYSE-M) 7/2/19 $10 Ph II CNS Pharmaceuticals Inc....
BioCentury | Jul 13, 2019
Finance

How crossover, insider support and big money correlated with performance across 1H19 IPOs

...7/3/19 Up to $100.2 Mkt (drug) Livongo Health Inc. 6/28/19 Up to $100 Mkt (tools) CNS Pharmaceuticals Inc....
BioCentury | Jun 28, 2019
Financial News

June 28 Financial Quick Takes: Karuna rises after IPO; plus Chi-Med, BeiGene and more

...and market capitalization thresholds for a general listing. Brain cancer company files for NASDAQ IPO CNS Pharmaceuticals Inc....
...2020 (see "Aslan's Change of Course" ). Paul Bonanos, Associate Editor BeiGene Ltd. Hutchison China MediTech Ltd. Karuna Therapeutics Inc. berubicin CNS Pharmaceuticals Inc....
Items per page:
1 - 3 of 3